33983-39-0 Usage
General Description
Medicarpin(P) is a chemical compound that belongs to the group of pterocarpans, which are natural compounds found in certain plants. It is primarily found in the Medicago species of plants, such as alfalfa and clover. Medicarpin(P) has been studied for its potential pharmaceutical and agricultural applications, including its antimicrobial, antifungal, and anti-inflammatory properties. It has also been researched for its potential role in enhancing plant resistance to diseases and pests. Overall, medicarpin(P) is a bioactive compound with various potential uses in medicine and agriculture due to its unique chemical properties.
Check Digit Verification of cas no
The CAS Registry Mumber 33983-39-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,9,8 and 3 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 33983-39:
(7*3)+(6*3)+(5*9)+(4*8)+(3*3)+(2*3)+(1*9)=140
140 % 10 = 0
So 33983-39-0 is a valid CAS Registry Number.
InChI:InChI=1/C16H14O4/c1-18-10-3-5-11-13-8-19-14-6-9(17)2-4-12(14)16(13)20-15(11)7-10/h2-7,13,16-17H,8H2,1H3/t13-,16-/m1/s1
33983-39-0Relevant articles and documents
A general asymmetric route to enantio-enriched isoflavanes via an organocatalytic annulation of o-quinone methides and aldehydes
Zhang, Jian,Zhang, Shuangzhan,Yang, Huixin,Zhou, Ding,Yu, Xueting,Wang, Wei,Xie, Hexin
supporting information, p. 2407 - 2411 (2018/05/24)
Reported herein is a general approach to optically active isoflavanes based on a chiral amine-catalyzed [4 + 2] asymmetric annulation of o-quinone methides and aldehydes. A number of naturally occurring isoflavanes, including equol, sativan, isosativan, v
Total Synthesis of (+)-Medicarpin
Yang, Xiaoming,Zhao, Yu,Hsieh, Min-Tsang,Xin, Guang,Wu, Rong-Tsun,Hsu, Pei-Lun,Horng, Lin-Yea,Sung, Hui-Ching,Cheng, Chien-Hsin,Lee, Kuo-Hsiung
, p. 3284 - 3288 (2018/01/02)
(+)-Medicarpin has been synthesized asymmetrically for the first time in a linear scalable process with an overall yield of 11%. The two chiral centers were constructed in one step via condensation using a chiral oxazolidinone auxiliary. This method will likely accelerate research on medicarpin as an erythropoietin inducer for erythropoietin-deficient diseases.